Pioneering The Next Generation of Solid Tumor T Cell Immunotherapies Who We Are Focusing on improving the lives of patients with solid tumor cancers. Our Science Developing the most mature bispecific T cell engaging platform in its class. Pipeline Advancing our COBRA™ pipeline toward the clinic.
